---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-006448"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2026-01-22T23:59:59+00:00"
generated_at: "2026-05-16T08:56:13.518901+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Incannex Healthcare forms Clinical Advisory Board for PSX-001 anxiety program

## Summary
- Clinical Advisory Board (CAB) established to support PSX-001 development for generalized anxiety disorder.
- CAB will advise on trial design, endpoint selection, regulatory engagement, and strategic approach.
- Inaugural members: Dr. C. Neill Epperson, Dr. Charles B. Nemeroff, and Dr. Alan F. Schatzberg.
- CMO Dr. Lou Barbato says CAB will help inform key development decisions and support shareholder value.

## SEC filing metadata
- accession: 0001213900-26-006448
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2026-01-22T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390026006448/0001213900-26-006448-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390026006448/ea0273695-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-006448
- JSON: https://secwatch.observer/filing/0001213900-26-006448.json
- Plain text: https://secwatch.observer/filing/0001213900-26-006448.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.